CURIS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CURIS, INC. (CRIS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.85 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14
- CURIS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 97.05M shares, a 665.29% increase year-over-year.
- CURIS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 12.68M shares, a 936.99% increase year-over-year.
- CURIS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 1.22M shares.
- CURIS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2015-09-30 was 13.68M shares, a 7.39% increase year-over-year.
- CURIS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 16.48M shares, a 357.89% increase from fiscal 2024.
- CURIS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 3.60M shares.
- CURIS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 10.36M shares, a 19.56% increase from fiscal 2020.
- CURIS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 8.67M shares, a 40.76% increase from fiscal 2019.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.85M shares 10-Q · filed 2026-08-14 | |||||||
| 2026-03-31 | 97.05M shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 16.48M shares 10-K · filed 2026-03-24 | |||||||
| 2025-09-30 | 16.43M shares 10-Q · filed 2025-11-06 | |||||||
| 2025-06-30 | 671.37K shares 10-Q · filed 2026-08-14 | 13.43M shares 10-Q · filed 2025-08-05 | ||||||
| 2025-03-31 | 12.68M shares 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | 3.60M shares 10-K · filed 2026-03-24 | |||||||
| 2024-09-30 | 1.20M shares 10-Q · filed 2025-11-06 | |||||||
| 2024-06-30 | 1.27M shares 10-Q · filed 2025-08-05 | |||||||
| 2024-03-31 | 1.22M shares 10-Q · filed 2025-05-06 | |||||||
| 2021-12-31 | 10.36M shares 10-K · filed 2022-02-24 | |||||||
| 2020-12-31 | 8.67M shares 10-K · filed 2022-02-24 | |||||||
| 2019-12-31 | 6.16M shares 10-K · filed 2022-02-24 | |||||||
| 2018-12-31 | 3.71M shares 10-K · filed 2020-03-19 | |||||||
| 2017-12-31 | 3.21M shares 10-K · filed 2019-03-26 | 16.03M shares 10-K · filed 2018-03-08 | ||||||
| 2016-12-31 | 13.75M shares 10-K · filed 2018-03-08 | |||||||
| 2015-12-31 | 13.29M shares 10-K · filed 2018-03-08 | |||||||
| 2015-09-30 | 13.68M shares 10-Q · filed 2015-11-09 | 13.68M shares 10-Q · filed 2015-11-09 | ||||||
| 2015-06-30 | 13.55M shares 10-Q · filed 2015-08-06 | 13.55M shares 10-Q · filed 2015-08-06 | ||||||
| 2015-03-31 | 12.65M shares 10-Q · filed 2015-05-07 | |||||||
| 2014-12-31 | 12.69M shares 10-K · filed 2017-03-09 | |||||||
| 2014-09-30 | 12.74M shares 10-Q · filed 2015-11-09 | 12.74M shares 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | 12.76M shares 10-Q · filed 2015-08-06 | 12.76M shares 10-Q · filed 2015-08-06 | ||||||
| 2014-03-31 | 12.71M shares 10-Q · filed 2015-05-07 | |||||||
| 2013-12-31 | 11.45M shares 10-K · filed 2016-02-29 | |||||||
| 2013-09-30 | 11.91M shares 10-Q · filed 2014-11-10 | 11.91M shares 10-Q · filed 2014-11-10 | ||||||
| 2013-06-30 | 12.04M shares 10-Q · filed 2014-08-07 | 12.04M shares 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | 13.12M shares 10-Q · filed 2014-05-09 | |||||||
| 2012-12-31 | 11.81M shares 10-K · filed 2015-02-24 | |||||||
| 2012-09-30 | 11.87M shares 10-Q · filed 2013-11-12 | 11.87M shares 10-Q · filed 2012-11-06 | 11.87M shares 10-Q · filed 2013-11-12 | 11.87M shares 10-Q · filed 2012-11-06 | ||||
| 2012-06-30 | 12.12M shares 10-Q · filed 2013-08-08 | 12.12M shares 10-Q · filed 2013-08-08 | ||||||
| 2011-12-31 | 12.71M shares 10-K · filed 2014-03-13 | |||||||
| 2011-09-30 | 13.10M shares 10-Q · filed 2012-11-06 | 13.10M shares 10-Q · filed 2012-11-06 | ||||||
| 2011-06-30 | 13.44M shares 10-Q · filed 2012-08-09 | 13.44M shares 10-Q · filed 2012-08-09 | ||||||
| 2010-12-31 | 13.15M shares 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |